Zoetis

NAVC is accepting entries for its 2024 VETTY Awards, recognizing marketing excellence in animal health care across various mediums. Winners will be announced at the Veterinary Meeting and Expo in Orlando, January 25-29, 2025. The early bird deadline for submissions is October 18, 2024, with final deadline on November 6, 2024.

The Animal Biotechnology Market is projected to grow from USD XX billion in 2023 to USD XX billion by 2031, at a CAGR of XX% (2024-2031). The market is segmented by product, application, animal type, and end-use, with key players including Zoetis, Boehringer Ingelheim, Biogénesis Bagó, and Merck & Co. The report provides insights into market size, growth, revenue, and competitive landscape, focusing on regions like North America, Europe, and Asia Pacific.

2024 sees ongoing FTC scrutiny of life sciences transactions, including Novo's $16.5B Catalent acquisition and AbbVie's $8.7B Cerevel deal. The FTC challenges 'junk' patents in the FDA's Orange Book and releases an interim report on PBMs. The EU Commission opens its first abuse-of-dominance probe related to Zoetis shelving a veterinary therapy. Despite regulatory focus, deals in radiopharmaceuticals and metabolic diseases proceed without notable investigations.